Original document(7 pages) Authorized document(7 pages) 中文版
    Disclosed is a hemostatic injection of carbazochrome sodium sulfonate and method for preparation, wherein the injection comprises carbazochrome sodium sulfonate 0.005-0.5 wt%, the optimum content being 0.008-0.2%, auxiliary solvent 0.001-0.5 wt%, the optimum content being 0.002-0.1%, osmoregulation agent 0.8-15 wt%, and water for injection 84.0-99.1%. The preparing process consists of boiling, filtering, removing charcoal, adjusting pH to 4.5-6.5, passing soup through a charcoal layer, loading into transfusion bottles, venting nitrogen, rolling the caps, and sterilizing.
Application Number
申请号
200610012582 Application Date
申请日
2006.04.12
Title 名称 Hemostatic injection of carbazochrome sodium sulfonate and method for preparing the same
Publication Number
公开号
1827101 Publication Date
公开日
2006.09.06
Approval Pub. Date 2007.08.22 Granted Pub. Date 2007.08.22
International Classification 分类号 A61K31/404;A61K9/08;A61P7/04
Applicant(s) Name
申请人
Zhou Guirong
Address 地址
Inventor(s) Name 发明人 Zhou Guirong
Attorney & Agent 代理人
More information 更  多  信  息


 Related patents information
Butylbenzene phthalein cyclodextrin or cyclodextrin derivative clathrate, its preparation method and application
Active calcium nectar
Process for preparation of coated azithromycin micropill
Composite medicine for treating cerebrovascular diseases
Tramadol hydrochloride oral disintegration tablets, and prepn. method therefor
Oral disintegration tablets contg. p-acetaminophenol, and prepn. method therefor
Preparing method and usage of vitamin E clathrate
Medicine for treating acute ischemic cerebral apoplexy and its preparing method
Butyl benzene phthalein soft capsule and its preparation method
Medication for treating sleep disorder
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.